Myasthenia gravis-like syndrome presenting as a component of the paraneoplastic syndrome of lung adenocarcinoma in a nonsmoker.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4129963)

Published in Case Rep Oncol Med on July 23, 2014

Authors

Sahar Eivaz-Mohammadi1, Fernando Gonzalez-Ibarra2, Hesam Hekmatjou1, Rao Mikkilineni3, Amit Patel4, Amer K Syed5

Author Affiliations

1: Department of Internal Medicine, Jersey City Medical Center, Jersey City, NJ 07302, USA.
2: Department of Internal Medicine, Mount Sinai School of Medicine, Jersey City Medical Center, 355 Grand Street, Jersey City, NJ 07302, USA.
3: Department of Pulmonary and Critical Care, Jersey City Medical Center, Jersey City, NJ 07302, USA.
4: Department of Hematology and Oncology, Jersey City Medical Center, Jersey City, NJ 07302, USA.
5: Laureate National Institute of Medicine, Program Director Internal Medicine, Jersey City Medical Center, Jersey City, NJ 07302, USA.

Articles cited by this

Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94

Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc (2010) 3.25

Myasthenia gravis: past, present, and future. J Clin Invest (2006) 3.06

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med (1999) 2.12

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry (2000) 1.59

Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc (1993) 1.49

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry (1996) 1.39

Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol (1988) 1.27

Anesthetic implications of myasthenia gravis. Mt Sinai J Med (2002) 1.24

Epidemiology and etiology of lung cancer. Clin Chest Med (1993) 1.22

Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol (2008) 1.21

Update in lung cancer 2008. Am J Respir Crit Care Med (2009) 1.11

Neuronal-type alpha-bungarotoxin receptors and the alpha 5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines. Proc Natl Acad Sci U S A (1992) 0.97

Neuromuscular junction in health and disease. Br J Anaesth (2007) 0.94

Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer. Muscle Nerve (2010) 0.86

Thymic epithelial cell line expresses transcripts encoding alpha-3, alpha-5 and beta-4 subunits of acetylcholine receptors, responds to cholinergic agents and expresses choline acetyl transferase. An in vitro system to investigate thymic cholinergic mechanisms. J Neuroimmunol (2001) 0.85

Nicotinic neuronal acetylcholine receptor alpha-3 subunit transcription in normal and myasthenic thymus. Ann N Y Acad Sci (1993) 0.82